Clinical Trials Logo

Inflammation clinical trials

View clinical trials related to Inflammation.

Filter by:

NCT ID: NCT03991520 Recruiting - Endometriosis Clinical Trials

Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms

Start date: June 16, 2020
Phase: Early Phase 1
Study type: Interventional

All current FDA approved medications to treat endometriosis pain including danazol, GnRH agonists (Lupron, Zoladex and Synarel), GnRH antagonist (elagolix) and depo-provera prevent or contradict pregnancy. Therefore women suffering from endometriosis and trying to conceive have no medical options apart from pain meds. The purpose of this pilot study is to determine whether the anti-inflammatory, IL-1 inhibitor (anakinra) reduces pelvic pain due to endometriosis without altering menstrual cycles, which is an indicator of ovulatory function. Anakinra is an FDA approved injectable medication for the treatment of rheumatoid arthritis that is pregnancy category B.

NCT ID: NCT03989882 Completed - Inflammation Clinical Trials

Wheat Germ Supplementation Will Improve Markers of Gut Health, Inflammation, and Insulin Resistance in Overweight Adults

Start date: May 28, 2019
Phase: N/A
Study type: Interventional

The objective of this pilot study is to determine the effects of wheat germ (WG) supplementation on gut health and subsequent effects on markers of inflammation and insulin resistance in overweight individuals. WG is a by-product of wheat processing and an excellent source of omega-3 fatty acids, vitamin E, and fiber. A few studies have shown the health benefits of WG including gut modulatory potential, but the prebiotic functions of WG in humans remain in question and warrant further investigation.

NCT ID: NCT03989427 Completed - Plaque Clinical Trials

The Effectiveness of Brushing and Flossing Sequence on Control of Plaque and Gingival Inflammation

RCT
Start date: May 20, 2019
Phase: N/A
Study type: Interventional

This study evaluates the effectiveness of brushing and flossing sequence in the control of dental plaque and gingival inflammation.

NCT ID: NCT03988374 Completed - Dental Plaque Clinical Trials

Clinical Efficacy Evaluation of Three Dentifrices

Start date: February 22, 2018
Phase: Phase 2
Study type: Interventional

Clinical study to evaluate and compare the efficacy of two baking soda containing dentifrices, containing 20% and 35% baking soda, to a non-baking soda dentifrice for their ability to reduce gingivitis and plaque following 6-months of use.

NCT ID: NCT03986307 Completed - Aging Clinical Trials

The Effect of Omega-3 Supplementation on Muscle Functioning, Inflammation and Muscle Signaling

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Elderly are supplemented with either Omega-3 (3 x 1.1g per day) or placebo (corn oil) during 14 weeks. The last 12 weeks, supplementation is combined with resistance exercise training (3x per week) focusing on upper leg strength. In the present project, the investigators study whether differences in muscle strength and/or muscle mass between conditions can be explained by omega-3-induced effects on systemic or muscle inflammatory signaling, or differences in muscle molecular signaling.

NCT ID: NCT03981211 Recruiting - Hepatitis C Clinical Trials

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs

TOPIC
Start date: February 12, 2021
Phase: N/A
Study type: Interventional

This study will evaluate the proportion of patients achieving confirmed SVR12 (undetectable HCV RNA at time point 12 weeks plus post treatment commencement) in patients hospitalised for IRID (injecting related infectious diseases) and commencing inpatient DAA treatment within public hospital services.

NCT ID: NCT03978260 Completed - Anemia Clinical Trials

Preoperative Anaemia prevaLence In surgiCal patiEnts

ALICE
Start date: August 15, 2019
Phase:
Study type: Observational

Preoperative anaemia is common in surgery, with a prevalence between 10 and 50 %, and is an independent risk factor for morbidity and mortality. Anaemia is mostly the result of an inadequate erythropoiesis due to iron deficiency, lack of vitamin B12 or folate, and bone marrow diseases. Among the elderly, renal disease and chronic inflammation account for approximately one-third of all anaemia incidences. The aim of this study is to provide detailed data about the prevalence of preoperative deficiencies in iron, vitamin B12 and/or folate and the presence of underlying renal or chronic diseases in patients undergoing major surgery.

NCT ID: NCT03978156 Terminated - Sickle Cell Disease Clinical Trials

Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease

Start date: July 26, 2019
Phase: Phase 1
Study type: Interventional

This study is designed to address the feasibility of a randomized, double masked, cross-over study of dronabinol as a palliative agent in the treatment of pain, inflammation, and other complications of sickle cell disease (SCD).

NCT ID: NCT03976622 Not yet recruiting - Psoriasis Clinical Trials

Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata

INFLAMMAVit
Start date: June 3, 2019
Phase:
Study type: Observational

It is a study of translational research with mechanistically objectives and including biological samples of patients with chronic inflammatory disorders

NCT ID: NCT03976206 Withdrawn - Clinical trials for Stem Cell Transplant Complications

Very Small Embryonic-like Stem Cells for Facial Skin Antiaging

Start date: July 6, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to facial skin antiaging.